pCMV-SHP2 CS Citations (6)

Originally described in: SHP2 plasmids
Unpublished

Articles Citing pCMV-SHP2 CS

Articles
Role of protein tyrosine phosphatase SHP2 in barrier function of pulmonary endothelium. Grinnell KL, Casserly B, Harrington EO. Am J Physiol Lung Cell Mol Physiol. 2010 Mar;298(3):L361-70. doi: 10.1152/ajplung.00374.2009. Epub 2009 Dec 18. PubMed
The p75 receptor mediates axon growth inhibition through an association with PIR-B. Fujita Y, Takashima R, Endo S, Takai T, Yamashita T. Cell Death Dis. 2011 Sep 1;2:e198. doi: 10.1038/cddis.2011.85. PubMed
Tyrosine phosphatase SHP2 regulates the expression of acyl-CoA synthetase ACSL4. Cooke M, Orlando U, Maloberti P, Podesta EJ, Cornejo Maciel F. J Lipid Res. 2011 Nov;52(11):1936-48. doi: 10.1194/jlr.M015552. Epub 2011 Sep 8. PubMed
Src homology-2 domain-containing protein tyrosine phosphatase (SHP) 2 and p38 regulate the expression of chemokine CXCL8 in human astrocytes. Mamik MK, Ghorpade A. PLoS One. 2012;7(9):e45596. doi: 10.1371/journal.pone.0045596. Epub 2012 Sep 21. PubMed
Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase. Ruess DA, Heynen GJ, Ciecielski KJ, Ai J, Berninger A, Kabacaoglu D, Gorgulu K, Dantes Z, Wormann SM, Diakopoulos KN, Karpathaki AF, Kowalska M, Kaya-Aksoy E, Song L, van der Laan EAZ, Lopez-Alberca MP, Nazare M, Reichert M, Saur D, Erkan MM, Hopt UT, Sainz B Jr, Birchmeier W, Schmid RM, Lesina M, Algul H. Nat Med. 2018 Jul;24(7):954-960. doi: 10.1038/s41591-018-0024-8. Epub 2018 May 28. PubMed
Targeting SHP2 phosphatase in breast cancer overcomes RTK-mediated resistance to PI3K inhibitors. Heynen GJJE, Lisek K, Vogel R, Wulf-Goldenberg A, Alcaniz J, Montaudon E, Marangoni E, Birchmeier W. Breast Cancer Res. 2022 Apr 1;24(1):23. doi: 10.1186/s13058-022-01521-3. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.